A significant discovery in cancer research is emerging with the use of mini-antibodies to reactivate mutated p53. This essential malignant suppressor protein is frequently disabled in several forms of cancer, leading https://top100bookmark.com/story22124134/nanobodies-revive-the-p53-protein-the-promising-pathway-for-malignant-therapy